Biogen and City Therapeutics have announced a partnership worth over $1bn to develop new RNAi therapies. The collaboration ...

Sanofi has announced that it will be acquiring Vigil Neuroscience and its investigational Alzheimer’s disease (AD) drug for ...

These groundbreaking treatments offer new hope for patients to live longer and healthier lives. But ensuring patients benefit ...